Literature DB >> 9423278

A neuropsychological study of prefrontal lobe function in the positive and negative subtypes of schizophrenia.

D T Mattson1, M Berk, M D Lucas.   

Abstract

The symptoms of schizophrenia are frequently divided into positive and negative subtypes. It has been suggested that the negative symptoms are similar to those seen with prefrontal lobe cortical dysfunction. Several neuropsychological investigations of that hypothesis have been carried out, but none have directly compared a negative symptom group with a positive symptom group on the same test battery. In the present study, the Positive and Negative Syndrome Scale (PANSS; Kay, Fiszbein, & Opler, 1987) was used to distinguish two groups of 20 patients with schizophrenia with predominant positive or negative symptoms. A battery of 7 neuropsychological tests considered capable of isolating prefrontal lobe dysfunction was administered. A significant group difference was noted on 6 of the tests; the negative symptom group performed much worse than the positive symptom group. The results of this study support the hypothesis that a relationship exists between the negative symptoms of schizophrenia and prefrontal lobe dysfunction.

Entities:  

Mesh:

Year:  1997        PMID: 9423278     DOI: 10.1080/00221329709596685

Source DB:  PubMed          Journal:  J Genet Psychol        ISSN: 0022-1325            Impact factor:   1.509


  10 in total

Review 1.  Profiles of neuropsychologic function in schizophrenia.

Authors:  J Daniel Ragland
Journal:  Curr Psychiatry Rep       Date:  2003-08       Impact factor: 5.285

Review 2.  Behavior at the choice point: decision making in hidden pathway maze learning.

Authors:  Elizabeth Thomas; Peter J Snyder; Robert H Pietrzak; Paul Maruff
Journal:  Neuropsychol Rev       Date:  2014-10-28       Impact factor: 7.444

3.  Transdiagnostic neural markers of emotion-cognition interaction in psychotic disorders.

Authors:  Amri Sabharwal; Akos Szekely; Roman Kotov; Prerona Mukherjee; Hoi-Chung Leung; Deanna M Barch; Aprajita Mohanty
Journal:  J Abnorm Psychol       Date:  2016-09-12

4.  Neuropsychological profiles delineate distinct profiles of schizophrenia, an interaction between memory and executive function, and uneven distribution of clinical subtypes.

Authors:  S Kristian Hill; J Daniel Ragland; Ruben C Gur; Raquel E Gur
Journal:  J Clin Exp Neuropsychol       Date:  2002-09       Impact factor: 2.475

Review 5.  A systematic review of research on neuropsychological measures in psychotic disorders from low and middle-income countries: The question of clinical utility.

Authors:  Emmanuel K Mwesiga; Dickens Akena; Nastassja Koen; Richard Senono; Ekwaro A Obuku; Joy Louise Gumikiriza; Reuben N Robbins; Noeline Nakasujja; Dan J Stein
Journal:  Schizophr Res Cogn       Date:  2020-08-24

6.  Neuropsychological and cerebral morphometric aspects of negative symptoms in schizophrenia: negative symptomatology is associated with specific mnestic deficits in schizophrenic patients.

Authors:  Tobias Hornig; Gabi Valerius; Bernd Feige; Emanuel Bubl; Hans M Olbrich; Ludger Tebartz van Elst
Journal:  BMC Psychiatry       Date:  2014-11-25       Impact factor: 3.630

7.  Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca's area volume.

Authors:  S G Fillman; T W Weickert; R K Lenroot; S V Catts; J M Bruggemann; V S Catts; C S Weickert
Journal:  Mol Psychiatry       Date:  2015-07-21       Impact factor: 15.992

8.  Transcranial Direct Current Stimulation Over Prefrontal Areas Improves Psychomotor Inhibition State in Patients With Traumatic Brain Injury: A Pilot Study.

Authors:  Xu Zhang; Baohu Liu; Nan Li; Yuanyuan Li; Jun Hou; Guoping Duan; Dongyu Wu
Journal:  Front Neurosci       Date:  2020-05-20       Impact factor: 4.677

9.  Supplementation of Antipsychotic Treatment with the Amino Acid Sarcosine Influences Proton Magnetic Resonance Spectroscopy Parameters in Left Frontal White Matter in Patients with Schizophrenia.

Authors:  Dominik Strzelecki; Michał Podgórski; Olga Kałużyńska; Oliwia Gawlik-Kotelnicka; Ludomir Stefańczyk; Magdalena Kotlicka-Antczak; Agnieszka Gmitrowicz; Piotr Grzelak
Journal:  Nutrients       Date:  2015-10-22       Impact factor: 5.717

10.  Adding Sarcosine to Antipsychotic Treatment in Patients with Stable Schizophrenia Changes the Concentrations of Neuronal and Glial Metabolites in the Left Dorsolateral Prefrontal Cortex.

Authors:  Dominik Strzelecki; Michał Podgórski; Olga Kałużyńska; Ludomir Stefańczyk; Magdalena Kotlicka-Antczak; Agnieszka Gmitrowicz; Piotr Grzelak
Journal:  Int J Mol Sci       Date:  2015-10-15       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.